April 19, 2012
1 min read
Save

Intensified tests may improve effectiveness, costs of colorectal cancer screenings

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Increasing the frequency of one-sample faecal immunochemical tests or collecting two samples at a time may increase performance of colorectal cancer screenings, though it may be less cost-effective, according to study results.

Researchers examined the costs and benefits of strategies with either one- or two-sample faecal immunochemical test (FIT) screenings using a MISCAN–colon microsimulation model. They set the FIT cut-off level to include 50 to 200 ng haemoglobin/ml and considered the following definitions for positivity of the two-sample FIT: at least one positive sample, two positive samples, or the mean of both samples being positive. The screening schedule was varied with respect to age range and interval.

Among a group of patients aged 55 to 75 years, one-sample FIT (n=9,132) provided a 76 to 97 life-years gained (LYG) per 1,000 individuals, at a cost of €259 000 to €264 000 ($337.45-$344.47; range reflects different FIT cut-off levels). At an extra cost of €50 000 to €59 000 ($65.14-$76.87), an additional 7.3 to 12.4 LYG was provided from a two-sample FIT screening (n=1,874) with at least one sample being positive. When all screening intervals and age ranges were considered, researchers said, intensifying screenings with one-sample FIT provided equal or more LYG at lower costs compared with two-sample FIT.

“Our analysis demonstrates that given a screening schedule [ie, age range and screening interval], two-sample FIT strategies with the mean from both test results being positive or at least one positive test outcome provide more LYG at acceptable costs than one-sample FIT screening,” researchers said. “However, when all simulated screening strategies are considered, increasing the screening intensity of one-sample FIT testing is more cost-effective than providing two FIT within one screening round.”